基因型和家族史作为突发心脏病死亡的风险标志物 超缩性心肌病症
Ali Sakhnini1, Mahdi Montazeri1, Cindy Chow1
1Division of Cardiology, Peter Munk Cardiac Centre, University Health Network and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
JACC. Clinical electrophysiology
|March 6, 2026
概括
突发心脏病死亡 (SCD) 的家族病史是高性心肌病 (HCM) 的独立风险标志物. 基因型阳性患者有SCD家族病史面临更高的风险,建议针对性的ICD干预措施.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 突发心脏病死亡研究研究
背景情况:
- 有限的数据存在于突发心脏病死亡 (SCD) 的遗传标记在缩性心肌病 (HCM).
- 无论基因型如何,在HCM中由家族史SCD (FHxSCD) 赋予的独立风险仍然不清楚.
研究的目的:
- 评估HCM患者的基因型,FHxSCD和SCD结局之间的关联.
- 探索将遗传信息整合到SCD风险分层模型中.
主要方法:
- 一项历史上的队列研究,涉及来自两个HCM转诊中心的3,258名患者.
- 使用多变量危险回归分析来评估FHxSCD和基因型与SCD的关联.
主要成果:
- 无论是FHxSCD (HR: 1.83) 还是基因型阳性 (HR: 1.52) 都与增加SCD风险独立相关.
- 在患有FHxSCD且没有其他风险因素的患者中,基因型阳性个体在5年内患有SCD的风险为6.4%,而基因型阴性个体的风险为2.6%.
结论:
- FHxSCD是成人HCM患者中SCD的独立风险标志物,即使考虑到基因型.
- 具有FHxSCD且没有其他风险标志物的基因型阳性患者有SCD的高风险.
- 大多数具有FHxSCD的基因型阴性患者可能不需要插入ICD,除非存在其他危险因素.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
588
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy I: Introduction and Classification
722
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Cardiomyopathy II: Dilated Cardiomyopathy
687
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Cardiomyopathy V: Interprofessional Care
558
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K


